Latest News

Winship research teams receive collaborative pilot grants

Two research teams from Winship Cancer Institute of Emory University (Winship) have been awarded pilot grants from the Donaldson Charitable Trust Research Synergy Fund, a unique funding opportunity offered jointly by Winship, the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, and the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.

Congratulations to the 2019 Imlay Innovation Grant Awardees

Enhancing Rehabilitation in Children With Genu Recurvatum Walking Gait Using Robotic Exoskeletons Georgia Tech: Aaron Young, PhD, Kinsey Herrin, CO, CP Children’s: Kelly Moore, DPT, Erin Eggebrecht, DPT Award Amount: $125,000 Pediatric Airway Support With a 3D Printed…

Warp Speed chief visits Emory, urges participation in COVID vaccine trials

Operation Warp Speed's Chief Science Advisor, Dr. Moncef Slaoui, visited Emory University and urged Americans to continue enrolling in ongoing COVID-19 vaccine trials.

Klosky receives grant for HPV vaccine uptake intervention

James Klosky, professor of pediatrics at Emory School of Medicine and director of psychology for the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta, and University of Alabama colleague Wendy Landier were awarded a $1.8 million U01 grant from the National Cancer Institute.

NIH supports study of arginine therapy for sickle cell pain

Claudia R. Morris, professor of pediatrics at Emory School of Medicine and pediatric emergency medicine physician at Children’s Healthcare of Atlanta, received $8.7 million from the NIH to determine if giving additional arginine can reduce pain during a sickle cell pain crisis. Morris will lead a multicenter study of intravenous arginine therapy in collaboration with the Aflac Cancer and Blood Disorders Center of Children’s. Too little arginine, a type of amino acid that helps regulate normal blood flow, may cause blood vessels to constrict, reducing blood flow and contributing to sickle-related pain.

Emory begins advanced stage clinical trial for another COVID-19 vaccine

Emory University will enroll adult volunteers in a large-scale clinical trial designed to evaluate whether a single dose of an investigational vaccine can prevent symptomatic COVID-19. The vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, moved to Phase 3 trials after encouraging results from an earlier clinical study. Our own, Evan Anderson, MD, is the principal investigator for the trial at Emory and professor of medicine and pediatrics at Emory University School of Medicine and Children’s Healthcare of Atlanta.

National Academy of Medicine elects two Emory researchers and leaders in 2020 class

Congratulations to Dr. Susan Margulies, interim director of CCNR on this prestigious honor.

The National Academy of Medicine (NAM) has elected Denise J. Jamieson, MD, MPH, and Susan Margulies, PhD, to its prestigious 2020 class, consisting of 100 new members. Election to NAM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

NIH Awards $18.2 million to Children’s, Emory and Georgia Tech to Continue Verification of COVID-19

Children’s Healthcare of Atlanta, the Emory University School of Medicine and the Georgia Institute of Technology have received an additional $18.2 million from the National Institutes of Health (NIH) to continue their verification of COVID-19 diagnostic tests. The funding is from the NIH’s Rapid Acceleration of Diagnostics (RADx) program, an initiative designed to transform innovative technologies into widely accessible COVID-19 diagnostic testing.